UroGen Pharma (URGN) Property, Plant & Equipment (Net) (2016 - 2026)

UroGen Pharma (URGN) Property, Plant & Equipment (Net) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 UroGen Pharma 2.07 Bn 1.93 Bn 46.82 Mn 616,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 616,000.00
Mar 31, 2026 616,000.00
Dec 31, 2025 637,000.00
Dec 31, 2025 637,000.00
Sep 30, 2025 695,000.00
Sep 30, 2025 695,000.00
Jun 30, 2025 688,000.00
Jun 30, 2025 688,000.00
Mar 31, 2025 627,000.00
Mar 31, 2025 627,000.00
Dec 31, 2024 655,000.00
Dec 31, 2024 655,000.00
Sep 30, 2024 608,000.00
Sep 30, 2024 608,000.00
Jun 30, 2024 580,000.00
Jun 30, 2024 580,000.00
Mar 31, 2024 566,000.00
Mar 31, 2024 566,000.00
Dec 31, 2023 689,000.00
Dec 31, 2023 689,000.00